Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Charles River Laboratories International Inc. (CRL)

118.81   1.22 (1.04%) 01-23 16:02
Open: 118.25 Pre. Close: 117.59
High: 120.85 Low: 116.24
Volume: 265,009 Market Cap: 5714M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 120.586 - 121.065 121.065 - 121.477
Low: 114.954 - 115.537 115.537 - 116.039
Close: 117.737 - 118.694 118.694 - 119.518

Technical analysis

as of: 2019-01-23 4:26:04 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. This stock is ready for a new bullish move. It is relatively safe to buy now, a new upward move is expected.
Target: Six months: 144.63     One year: 168.93
Support: Support1: 110.96    Support2: 103.00
Resistance: Resistance1: 123.83    Resistance2: 144.63
Pivot: 115.80
Moving Average: MA(5): 118.21     MA(20): 114.38
MA(100): 124.44     MA(250): 116.65
MACD: MACD(12,26): -0.58     Signal(9): -1.57
Stochastic oscillator: %K(14,3): 87.66     %D(3): 86.94
RSI: RSI(14): 51.56
52-week: High: 139.72  Low: 96.70  Change(%): 12.5
Average Vol(K): 3-Month: 41453  10-Days: 37678

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CRL has closed below upper band by 32.2%. Bollinger Bands are 0.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-01-17T08:30:00-05:00
Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference Call

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 48.10
Shares Float (M) 46.31
% Held by Insiders
% Held by Institutions 140.40
Shares Short (K) 1255
Shares Short P. Month (K)

Stock Financials

EPS 5.930
EPS Est. Current Year 5.100
EPS Est. Next Year 5.610
EPS Est. Next Quarter 1.300
Forward EPS 6.571
Book Value (p.s.) 4.550
PEG Ratio 1.67
Profit Margin 10.12
Operating Margin 15.93
Return on Assets (ttm) 4.1
Return on Equity (ttm) 12.1
Qtrly Rev. Growth 26.1
Gross Profit (p.s.) 3.488
Sales Per Share
EBITDA (p.s.) 2.292
Qtrly Earnings Growth 15.00
Operating Cash Flow (M) 421.35
Levered Free Cash Flow (M) 333.55

Stock Valuations

P/E 20.03
P/E Growth Ratio 0.01
P/BV 26.10
P/S 127696736.00
P/CF 13.56

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.